Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes
Elaine C. Chen(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Robert H. Carnahan(Vanderbilt University Medical Center), Alexander Bukreyev(Galveston College), Rachel E. Sutton(Vanderbilt University Medical Center), Natalie Castellana, Christopher Gainza(Vanderbilt University Medical Center), Summer Monroig(Vanderbilt University Medical Center), Kai Huang(Galveston College), Philipp A. Ilinykh(Houston Methodist), Pavlo Gilchuk(AstraZeneca (Japan)), Elad Binshtein, Edgar Davidson(Integral Molecular (United States)), Andrew Trivette, Chandrahaas R. Kona(Vanderbilt University Medical Center), Benjamin J. Doranz(Integral Molecular (United States)), Erica Ollmann Saphire(La Jolla Institute for Immunology), Joseph X. Reidy(Vanderbilt University Medical Center), Seth J. Zost(Vanderbilt University Medical Center), Samuel B. Day(Vanderbilt University Medical Center), Stefano Bonissone, Luke Myers(Vanderbilt University Medical Center)
Cited by 3
Related Papers
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Taxonomy of the order Mononegavirales: update 2016
|Archives of Virology|2016|506